Suma Krishnan - Feb 26, 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
President, R&D, Director, 10%+ Owner
Signature
/s/ Suma Krishnan
Stock symbol
KRYS
Transactions as of
Feb 26, 2024
Transactions value $
-$369,421
Form type
4
Date filed
2/28/2024, 09:39 PM
Previous filing
Dec 12, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Tax liability -$369K -2.35K -0.15% $157.00 1.57M Feb 26, 2024 Direct F1, F2
holding KRYS Common Stock 1.63M Feb 26, 2024 By Spouse F3
holding KRYS Common Stock 90K Feb 26, 2024 By SMK Trust
holding KRYS Common Stock 50K Feb 26, 2024 By Krishnan Family Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 7,100 shares of restricted stock on February 26, 2024.
F2 The closing price on February 26, 2024 of the Company's common stock on NASDAQ.
F3 Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
F4 Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.